Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16410 |
Otamixaban
FXV673,奥米沙班 |
Others | Others |
Otamixaban(FXV673) is an effective (Ki = 0.5 nM), selective, rapid-acting, competitive, and reversible fXa inhibitor. It also effectively inhibits both free and prothrombinase-bound fXa. | |||
T71835 |
Otamixaban HCl
|
Others | Others |
Otamixaban HCl is an experimental injectable anticoagulant direct factor Xa inhibitor, that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial. |